BioSpace News Archive

Genetown

Neon Therapeutics to Present Data from Ongoing Phase 1b NT-001 Clinical Trial at the European Society for Medical Oncology 2018 CongressCompany to Host Investor Conference Call and Webcast on October 22, 2018 at 8:00 a.m. ET

Neon Therapeutics, Inc. will be presented in an upcoming oral presentation at the European Society for Medical Oncology (ESMO) 2018 Congress taking place October 19-23, 2018 in Munich, Germany.

October 3, 2018
·
4 min read
Business

Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products

Emerald Health Therapeutics, Inc. has entered into a research agreement with VivaCell Biotechnologies Spain S.L.U.

October 3, 2018
·
6 min read
Biotech Bay

SI-BONE, Inc. Announces that NICE, the UK National Institute for Health and Care Excellence, Published Medical Technology Guidance Finding that the Evidence Supports Treatment of Sacroiliac Joint Pain with the iFuse Implant System®

The recommendation, unique to iFuse among sacroiliac joint fusion devices, concludes that using iFuse leads to improved pain relief, better quality of life and less disability compared to non-surgical management

October 3, 2018
·
3 min read
Business

Eagle Pharmaceuticals Enters into Agreement with USAMRICD to Evaluate Neuroprotective Effects of RYANODEX Secondary to Nerve Agent Exposure

The study will be conducted under a Cooperative Research and Development Agreement

October 3, 2018
·
5 min read
Deals

Life Biosciences Acquires Lua, Pioneering AI-Driven Healthcare Platform

“Dream Team” of Longevity-Focused R&D Start-Ups Adds Proprietary Data Engine

October 3, 2018
·
4 min read
FDA

ADMA BioCenters Receives FDA Approval for Third Plasma Collection Center

Is now FDA licensed to collect and enter into interstate commerce to sell and use the human source plasma for further manufacturing in the U.S.

October 3, 2018
·
6 min read
Pharm Country

CytoSorbents to Present at the Cantor Fitzgerald Global Healthcare Conference

Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present an overview of the company at the Cantor Fitzgerald Global Healthcare Conference today in New York City at the InterContinental New York Barclay Hotel.

October 3, 2018
·
4 min read
Business

Purolite Ready to Lower the Cost of Protein A, With Opening of 100,000L-capacity UK Agarose Manufacturing Facility in Wales, UK

Purolite Ltd. today announces the opening of a state-of-the-art agarose resin manufacturing facility. Capable of producing 100,000L annually

October 3, 2018
·
3 min read
Neovasc Announces Positive 12-week Follow-up Data from the First U.S. Patient Implanted with a Neovasc Reducer

The Compassionate Use case was conducted in June 2018.

October 3, 2018
·
9 min read
Business

Forty Seven Inc. Appoints Leading Experts in Immuno-Oncology to its Scientific Advisory Board (SAB)

Forty Seven Inc. (NASDAQ:FTSV) today announced the formation of its Scientific Advisory Board (SAB), comprised of four leading scientists in the fields of immunotherapy and oncology.

October 3, 2018
·
8 min read